Labshake search
Citations for Cayman Chemical :
1 - 12 of 12 citations for "SB 431542" since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... SB-431542 (2 µM, Cayman Chemicals) and hLIF (10 ng/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... SB-431542 (2 µM, Cayman Chemicals) and hLIF (10 ng/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... SB-431542 (2 µM, Cayman Chemicals) and hLIF (10 ng/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... SB-431542 (2 µM) (Cayman Chemical), and hLIF (10 ng/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... and 10 μM SB-431542 (Cayman Chemicals) in DMEM/F12 containing 20% KnockOut Serum (Gibco) ...
-
bioRxiv - Pathology 2023Quote: ... SB-431542 (10 μM) (Cayman Chemical, USA) was used to selectively inhibit TGF-β1/ALK5-smad2/3 signaling cascade ...
-
bioRxiv - Developmental Biology 2023Quote: ... SB-431542 at 10μM (CAY13031, Cayman Chemical) 4ng/ml FGF2 (SRP3043 ...
-
bioRxiv - Cell Biology 2023Quote: ... SB-431542 was from Cayman Chemical (13031), bumetanide (B3023 ...
-
bioRxiv - Microbiology 2021Quote: ... HPI-1 and SB-431542 was purchased from Cayman Chemical, sofosbuvir was purchased from MedChemExpress ...
-
bioRxiv - Genomics 2020Quote: ... SB-431542 and dorsomorphin were removed and 150 µM ascorbic acid (Cayman Chemical Company) was added to the media ...
-
bioRxiv - Cell Biology 2020Quote: ... and 10 μM of transforming growth factor-β (TGF-β) type I receptor inhibitor (SB-431542; Cayman Chemicals).
-
bioRxiv - Pathology 2023Quote: ... both models were divided into different groups that either received a TGF-β1 receptor kinase inhibitor injection (SB-431542, Cayman Chemical, USA) or SHAM PBS ...